About Ishita Drugs & Industries Ltd
Ishita Drugs & Industries is engaged in the business of manufacturing of various APIs (Active Pharma Ingredients) and drug intermediates. It has built up a reputation as a manufacturer of “high quality” products and is known for its ethical dealings in business.
Founded
1992
CEO
Jagdish Agrawal
Employees
14
HQ
Ahmedabad, India
Finished Products
1Sales
₹30.18CrRaw Materials
1Raw Material
₹21.41Cr2Purchase
₹0.40Cr3Packing Material
₹0.08CrAbout Ishita Drugs & Industries Ltd
Ishita Drugs & Industries is engaged in the business of manufacturing of various APIs (Active Pharma Ingredients) and drug intermediates. It has built up a reputation as a manufacturer of “high quality” products and is known for its ethical dealings in business.
Founded:1992
CEO:Jagdish Agrawal
Employees:14
HQ:Ahmedabad, India
Finished Products
1Sales
₹30.18CrRaw Materials
1Raw Material
₹21.41Cr2Purchase
₹0.40Cr3Packing Material
₹0.08CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹91
52W Low
₹66
Volume214
Avg VolumeN/A
Beta0.51
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
30.46x
Valuation
P/B Ratio
1.86x
Valuation
EPS
₹2.36
Valuation
Dividend Yield
0.00%
Valuation
ROE
6.73%
Profitability
ROCE
9.78%
Profitability
Revenue by Segment
Contribution & growth by business line
No segment revenue data available
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.01x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-1.2%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.